Promotion of osteochondral repair through immune microenvironment regulation and activation of endogenous chondrogenesis via the release of apoptotic vesicles from donor MSCs
Source abstract
Abstract
Utilizing transplanted human umbilical cord mesenchymal stem cells (HUMSCs) for cartilage defects yielded advanced tissue regeneration, but the underlying mechanism remain elucidated. Early after HUMSCs delivery to the defects, we observed substantial apoptosis. The released apoptotic vesicles (apoVs) of HUMSCs promoted cartilage regeneration by alleviating the chondro-immune microenvironment. ApoVs triggered M2 polarization in macrophages while simultaneously facilitating the chondrogenic differentiation of endogenous MSCs. Mechanistically, in macrophages, miR-100-5p delivered by apoVs activated the MAPK/ERK signaling pathway to promote M2 polarization. In MSCs, let-7i-5p delivered by apoVs promoted chondrogenic differentiation by targeting the eEF2K/p38 MAPK axis. Consequently, a cell-free cartilage regeneration strategy using apoVs combined with a decellularized cartilage extracellular matrix (DCM) scaffold effectively promoted the regeneration of osteochondral defects. Overall, new mechanisms of cartilage regeneration by transplanted MSCs were unconcealed in this study. Moreover, we provided a novel experimental basis for cell-free tissue engineering-based cartilage regeneration utilizing apoVs. Schematic summary of our main findings. Intraarticular injection of HUMSCs derived apoEVs delivers the miR-100-5p into macrophages and promotes M2 macrophage polarization by activating MAPK/ERK1/2 and delivers the let-7i-5p into MSCs and promotes chondrogenesis. The apoEVs combined with DCM scaffold facilitating cartilage defect repair. HUMSCs: human umbilical cord-derived mesenchymal stem cells, DCM: decellularized cartilage matrix. • This study provides the first evidence of short-term apoptosis of MSCs after implantion in cartilage defect. • HUMSC-apoVs induce macrophage immunomodulation, promoting MSC chondrogenic differentiation. • TmiR-100-5p in apoVs activated the MAPK/ERK pathway to induce macrophage M2 polarization. • Let-7i-5p in apoVs promoted chondrogenic differentiation by targeting the eEF2K/p38 MAPK axis. • A cell-free strategy of apoVs combined with DCM scaffold promoted cartilage regeneration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (87)
Show source-provided references
1. Stem cell therapies in clinical trials: progress and challenges10.1016/j.stem.2015.06.007 ↗
2. Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc regeneration
3. Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritis10.1016/j.arr.2022.101684 ↗
4. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities10.1016/j.stem.2018.05.004 ↗
5. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential10.1016/j.tips.2020.06.009 ↗
6. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs10.1016/j.stem.2012.04.009 ↗
7. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue10.1152/physrev.00019.2015 ↗
8. Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery10.1016/j.jconrel.2023.01.059 ↗
9. Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs
10. Research progress on stem cell therapies for articular cartilage regeneration10.1155/2021/8882505 ↗
11. Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy10.1038/s41419-021-03883-6 ↗
12. Apoptotic vesicles activate autophagy in recipient cells to induce angiogenesis and dental pulp regeneration10.1016/j.ymthe.2022.05.006 ↗
13. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation10.1126/scitranslmed.aam7828 ↗
14. Human umbilical cord Wharton's jelly mesenchymal stem cells combined with an acellular cartilage extracellular matrix scaffold improve cartilage repair compared with microfracture in a caprine model10.1016/j.joca.2018.01.019 ↗
15. Coculture of hWJMSCs and pACs in oriented scaffold enhances hyaline cartilage regeneration in vitro10.1155/2019/5130152 ↗
16. Apoptotic cell-derived extracellular vesicles: more than just debris10.3389/fimmu.2018.01486 ↗
17. Apoptotic cell-derived extracellular vesicles: structure–function relationships10.1042/BST20180080 ↗
18. Metabolites released from apoptotic cells act as tissue messengers10.1038/s41586-020-2121-3 ↗
19. Apoptotic cell-derived extracellular vesicles: more than just debris10.3389/fimmu.2018.01486 ↗
20. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways10.1016/j.devcel.2004.08.019 ↗
21. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes10.1002/jev2.12109 ↗
22. Apoptotic extracellular vesicles derived from hypoxia-preconditioned mesenchymal stem cells within a modified gelatine hydrogel promote osteochondral regeneration by enhancing stem cell activity and regulating immunity10.1186/s12951-024-02333-7 ↗
23. Apoptotic extracellular vesicles restore homeostasis of the articular microenvironment for the treatment of rheumatoid arthritis
24. Killers creating new life: caspases drive apoptosis-induced proliferation in tissue repair and disease10.1038/cdd.2017.47 ↗
25. Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration10.1016/j.devcel.2009.07.014 ↗
26. Apoptosis and compensatory proliferation signaling are coupled by CrkI-containing microvesicles10.1016/j.devcel.2017.05.014 ↗
27. Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance10.1038/s41467-019-09010-6 ↗
28. Enhancement of acellular cartilage matrix scaffold by Wharton's jelly mesenchymal stem cell-derived exosomes to promote osteochondral regeneration
29. Cell-free decellularized cartilage extracellular matrix scaffolds combined with interleukin 4 promote osteochondral repair through immunomodulatory macrophages: in vitro and in vivo preclinical study10.1016/j.actbio.2021.03.054 ↗
30. In vivo cartilage repair using adipose-derived stem cell-loaded decellularized cartilage ECM scaffolds10.1002/term.1538 ↗
31. Cartilage regeneration using human umbilical cord blood derived mesenchymal stem cells: a systematic review and meta-analysis10.3390/medicina58121801 ↗
32. Clinical and magnetic resonance imaging outcomes after human cord blood–derived mesenchymal stem cell implantation for chondral defects of the knee10.1177/23259671231158391 ↗
33. Mesenchymal stem cells - a promising strategy for treating knee osteoarthritis10.1302/2046-3758.910.BJR-2020-0031.R3 ↗
34. Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons10.1002/stem.2475 ↗
35. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy10.1155/2015/632902 ↗
36. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice10.1038/s41419-021-03839-w ↗
37. A self-amplifying loop of TP53INP1 and P53 drives oxidative stress-induced apoptosis of bone marrow mesenchymal stem cells10.1007/s10495-023-01934-1 ↗
38. The prognosis of cancer depends on the interplay of autophagy, apoptosis, and anoikis within the tumor microenvironment10.1007/s12013-023-01179-4 ↗
39. Synthetic activators of autophagy10.1134/S0006297924010024 ↗
40. Arthritic microenvironment-dictated fate decisions for stem cells in cartilage repair
41. Cell death: a review of the major forms of apoptosis, necrosis and autophagy10.1002/cbin.11137 ↗
42. The clearance of dead cells by efferocytosis10.1038/s41580-020-0232-1 ↗
43. Efferocytosis in health and disease10.1038/s41577-019-0240-6 ↗
44. Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells10.1080/15548627.2020.1717128 ↗
45. In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: a therapy for intrauterine adhesions
46. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes10.1002/jev2.12109 ↗
47. Apoptotic cell-derived extracellular vesicles: more than just debris10.3389/fimmu.2018.01486 ↗
48. Apoptotic mitochondrial poration by a growing list of pore‐forming BCL‐2 family proteins10.1002/bies.202200221 ↗
49. Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for fas-mediated apoptosis in human leukemic cells10.1124/mol.112.080788 ↗
50. Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug10.1007/s12032-021-01532-8 ↗
51. P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma10.1111/j.1582-4934.2008.00590.x ↗
52. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family10.1101/gad.14.6.704 ↗
53. Extracellular HSP60 triggers tissue regeneration and wound healing by regulating inflammation and cell proliferation10.1038/npjregenmed.2016.13 ↗
54. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH10.1016/j.redox.2020.101634 ↗
55. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors10.1186/s12885-021-07996-1 ↗
56. Novel expression profiles of microRNAs suggest that specific miRNAs regulate gene expression for the sexual maturation of female Schistosoma japonicum after pairing10.1186/1756-3305-7-177 ↗
57. Macrophage polarization10.1146/annurev-physiol-022516-034339 ↗
58. The miR-21-5p enriched in the apoptotic bodies of M2 macrophage-derived extracellular vesicles alleviates osteoarthritis by changing macrophage phenotype10.1016/j.gendis.2022.09.010 ↗
59. Li-Mg-Si bioceramics provide a dynamic immuno-modulatory and repair-supportive microenvironment for peripheral nerve regeneration
60. Biomimetic and NOS‐responsive nanomotor deeply delivery a combination of MSC‐EV and mitochondrial ROS scavenger and promote heart repair and regeneration
61. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis10.1038/s41591-020-0939-8 ↗
62. Macrophage: a potential target on cartilage regeneration10.3389/fimmu.2020.00111 ↗
63. The role of macrophages in osteoarthritis and cartilage repair10.1016/j.joca.2019.12.007 ↗
64. ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling10.1074/jbc.RA117.000727 ↗
65. Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA110.1002/jcp.30213 ↗
66. MSC-derived small extracellular vesicles mitigate diabetic retinopathy by stabilizing Nrf2 through miR-143-3p-mediated inhibition of neddylation10.1016/j.freeradbiomed.2024.04.216 ↗
67. Decursinol angelate inhibits LPS-induced macrophage polarization through modulation of the NFκB and MAPK signaling pathways10.3390/molecules23081880 ↗
68. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways10.1016/j.cellsig.2013.11.004 ↗
69. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer10.1080/15384101.2018.1444305 ↗
70. Lactate secreted by esophageal cancer cells induces M2 macrophage polarization via the AKT/ERK pathway10.1111/1759-7714.14998 ↗
71. Apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages and promote the proliferation and migration of ovarian cancer cells by activating the ERK signaling pathway
72. Endogenous repair and regeneration of injured articular cartilage: a challenging but promising therapeutic strategy10.14336/AD.2020.0902 ↗
73. Let-7i-5p functions as a putative osteogenic differentiation promoter by targeting CKIP-110.1007/s10616-020-00444-1 ↗
74. Circ_FBLN1 promotes the proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by regulating let-7i-5p/FZD4 axis and Wnt/β-catenin pathway10.1007/s10863-021-09917-0 ↗
75. Exosomal let-7i-5p from three-dimensional cultured human umbilical cord mesenchymal stem cells inhibits fibroblast activation in silicosis through targeting TGFBR1
76. Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts10.1016/j.yexcr.2018.01.019 ↗
77. Differential effects of p38 and Erk1/2 on the chondrogenic and osteogenic differentiation of dental pulp stem cells10.3892/mmr.2017.6563 ↗
78. MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway10.1111/j.1365-2184.2010.00682.x ↗
79. The regulatory mechanism of p38/MAPK in the chondrogenic differentiation from bone marrow mesenchymal stem cells10.1186/s13018-019-1505-2 ↗
80. Osteoarthritis10.1016/S0140-6736(14)60802-3 ↗
81. Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies10.1038/s41584-023-00979-5 ↗
82. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells10.1016/j.biomaterials.2008.01.037 ↗
83. In vivo cartilage repair using adipose-derived stem cell-loaded decellularized cartilage ECM scaffolds10.1002/term.1538 ↗
84. Co-culture of hWJMSCs and pACs in double biomimetic ACECM oriented scaffold enhances mechanical properties and accelerates articular cartilage regeneration in a caprine model10.1186/s13287-020-01670-2 ↗
85. Enhancement of acellular cartilage matrix scaffold by Wharton's jelly mesenchymal stem cell-derived exosomes to promote osteochondral regeneration
86. (Mesenchymal) stem cell-based therapy in cisplatin-induced acute kidney injury animal model: risk of immunogenicity and tumorigenicity10.1155/2017/7304643 ↗
87. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies10.5966/sctm.2014-0110 ↗